Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 443 record(s)

Req # A-2021-000176

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03745244.

Organization: Health Canada

29 page(s)
July 2021

Req # A-2021-000178

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03744369.

Organization: Health Canada

10 page(s)
July 2021

Req # A-2021-000179

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03758009.

Organization: Health Canada

27 page(s)
July 2021

Req # A-2021-000180

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03742002.

Organization: Health Canada

9 page(s)
July 2021

Req # A-2021-000185

Adverse Reaction Reports (AERs) for Cyanocobalamin. Report numbers: E2B_02768927, E2B_02928900.

Organization: Health Canada

44 page(s)
July 2021

Req # A-2021-000218

Adverse Drug Reaction (ADR) for RIFAMPICIN. Report number: E2B_03400260.

Organization: Health Canada

12 page(s)
July 2021

Req # A-2021-000225

Adverse Reaction Reports (AERs). Report numbers: E2B_03072756, E2B_03320513, E2B_03674880, 000931004.

Organization: Health Canada

69 page(s)
July 2021

Req # A-2021-000229

Adverse Drug Reaction (ADR). Report number: E2B_03022558.

Organization: Health Canada

27 page(s)
July 2021

Req # A-2021-000258

Adverse Drug Reaction (ADR). Report number: 000933618.

Organization: Health Canada

3 page(s)
July 2021

Req # A-2021-000283

Adverse Drug Reaction (ADR) for METFORMIN HYDROCHLORIDE. Report number: E2B_03467451.

Organization: Health Canada

22 page(s)
July 2021
Date modified: